Comparison Chart Barinthus Biotherapeutics plc

Equities

Market Closed - Nasdaq Other stock markets 04:30:00 2024-07-10 pm EDT			5-day change	1st Jan Change
1.435 ^USD	-0.35%		+0.35%	-61.11%

Jun. 21	Top Premarket Gainers	MT
Jun. 13	Barclays Adjusts Price Target on Barinthus Biotherapeutics to $3 From $7, Maintains Overweight Rating	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	BARINTHUS BIOTHERAPEUTICS PLC	Other Biotechnology & Medical Research	-0.35%	+0.35%	-61.11%	-37.02%	-	56.01M